UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 233

Sortiert nach

Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial

The lancet oncology, 2017-05, Vol.18 (5), p.672-681

2017

Link zum Volltext

Verfügbarkeit prüfen

Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients

Cell reports (Cambridge), 2016-05, Vol.15 (6), p.1134-1143

2016

Link zum Volltext

Verfügbarkeit prüfen

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

Journal of clinical oncology, 2011-12, Vol.29 (35), p.4677-4681

2011

Link zum Volltext

Verfügbarkeit prüfen

Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas

OncoTargets and therapy, 2019-11, Vol.12, p.9265-9275

2019

Link zum Volltext

Verfügbarkeit prüfen

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

The Lancet (British edition), 2017-11, Vol.390 (10109), p.2266-2277

2017

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

The lancet oncology, 2009-11, Vol.10 (11), p.1045-1052

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Journal of clinical oncology, 2011-06, Vol.29 (18), p.2528-2533

2011

Link zum Volltext

Verfügbarkeit prüfen

Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma

Expert opinion on investigational drugs, 2019-01, Vol.28 (1), p.39-50

2019

Link zum Volltext

Verfügbarkeit prüfen

SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy

International journal of molecular sciences, 2023-07, Vol.24 (13), p.11143

2023

Link zum Volltext

Verfügbarkeit prüfen

Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)

Cancer chemotherapy and pharmacology, 2017-12, Vol.80 (6), p.1113-1131

2017

Link zum Volltext

Verfügbarkeit prüfen

Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas

Scientific reports, 2019-03, Vol.9 (1), p.3816-3816, Article 3816

2019

Link zum Volltext

Verfügbarkeit prüfen

2023 GEIS Guidelines for gastrointestinal stromal tumors

Therapeutic Advances in Medical Oncology, 2023-01, Vol.15, p.17588359231192388-17588359231192388

2023

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study

Investigational new drugs, 2018-06, Vol.36 (3), p.468-475

2018

Link zum Volltext

Verfügbarkeit prüfen

EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1

PloS one, 2013-08, Vol.8 (8), p.e71449-e71449

2013

Link zum Volltext

Verfügbarkeit prüfen

Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth

Oncotarget, 2014-10, Vol.5 (20), p.9744-9755

2014

Link zum Volltext

Verfügbarkeit prüfen

GEIS guidelines for gastrointestinal sarcomas (GIST)

Cancer treatment reviews, 2017-04, Vol.55, p.107-119

2017

Link zum Volltext

Verfügbarkeit prüfen

Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors

Clinical cancer research, 2009-05, Vol.15 (10), p.3384-3395

2009

Link zum Volltext

Verfügbarkeit prüfen

Optimization of the Therapeutic Approach to Patients with Sarcoma: Delphi Consensus

Sarcoma, 2019, Vol.2019, p.4351308-14

2019

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 233

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(225)

Publikationsform

Sprache

Englisch
(227)
Japanisch
(24)
Spanisch
(6)

Erscheinungsjahr

n.n

Thema

Science & Technology
(124)
Life Sciences & Biomedicine
(110)
Humans
(94)
Oncology
(90)
Male
(57)
Tumors
(49)
Adult
(40)
Female
(40)
Middle Aged
(37)
Aged
(32)
Antineoplastic Agents - Therapeutic Use
(27)
Prognosis
(27)
Biological And Medical Sciences
(23)
Chemotherapy
(23)
Medical Sciences
(23)
Neoplasm Staging
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(18)
Metastasis
(18)
Medicine
(16)
Disease-Free Survival
(15)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Maintenance therapy with vinflunine plus best supportive care versus best supportive care alone in patients with advanced urothelial carcinoma with a response after first-line chemotherapy (MAJA; SOGUG 2011/02): a multicentre, randomised, controlled, open-label, phase 2 trial

Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients

Risk-Adapted Treatment in Clinical Stage I Testicular Seminoma: The Third Spanish Germ Cell Cancer Group Study

Identification Of Actionable Genetic Targets In Primary Cardiac Sarcomas

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Randomized Phase II Study of Trabectedin and Doxorubicin Compared With Doxorubicin Alone as First-Line Treatment in Patients With Advanced Soft Tissue Sarcomas: A Spanish Group for Research on Sarcoma Study

Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma

SWI/SNF Complex Alterations in Tumors with Rhabdoid Features: Novel Therapeutic Approaches and Opportunities for Adoptive Cell Therapy

Malignant bone tumors (other than Ewing’s): clinical practice guidelines for diagnosis, treatment and follow-up by Spanish Group for Research on Sarcomas (GEIS)

Clinicopathological and Molecular Characterization of Metastatic Gastrointestinal Stromal Tumors with Prolonged Benefit to Frontline Imatinib

Bcl-xL inhibition enhances Dinaciclib-induced cell death in soft-tissue sarcomas

2023 GEIS Guidelines for gastrointestinal stromal tumors

Phase II trial of ifosfamide in combination with the VEGFR inhibitor sorafenib in advanced soft tissue sarcoma: a Spanish group for research on sarcomas (GEIS) study

EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1

A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study

Peripheral Inflammatory Indexes Neutrophil/Lymphocyte Ratio (NLR) and Red Cell Distribution Width (RDW) as Prognostic Biomarkers in Advanced Solitary Fibrous Tumour (SFT) Treated with Pazopanib

Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth

GEIS guidelines for gastrointestinal sarcomas (GIST)

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas

Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors

Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trial

Optimization of the Therapeutic Approach to Patients with Sarcoma: Delphi Consensus

Suchergebnisse filtern